nach oben

Erschienen in:

01.09.2005 | Short Communication

Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot–Marie–Tooth disease family

verfasst von: K. W. Chung, I. N. Sunwoo, S. M. Kim, K. D. Park, W.-K. Kim, T. S. Kim, H. Koo, M. Cho, J. Lee, B. O. Choi

Erschienen in: Neurogenetics | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

During mutational analysis of Charcot–Marie–Tooth (CMT) causative genes, we identified a CMT family with two missense mutations in different genes. A R359W mutation in EGR2 was shared by the affected daughter (proband) and her father. In addition, she had a V136A mutation in GJB1, which was determined to be a de novo mutation. The daughter with two different gene mutations showed more severe clinical, electrophysiological and histopathological phenotypes than her father who had only the EGR2 mutation. We suggest that these phenotypic differences between the proband and her father may have been caused by an altered effect of the genetic modifier in EGR2, or by the additive effect of the EGR2 and GJB1 mutations.

Harding AE (1995) From the syndrome of Charcot, Marie and Tooth to disorders of peripheral myelin proteins. Brain 118:809–818PubMedCrossRef

Suter U, Scherer SS (2003) Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 4:714–726CrossRefPubMed

Shy ME, Garbern JY, Kamholz J (2002) Hereditary motor and sensory neuropathies: a biological perspective. Lancet Neurol 1:110–118CrossRefPubMed

Nicholson SM, Gomes D, de Nechaud B, Bruzzone R (2001) Altered gene expression in Schwann cells of connexin32 knockout animals. J Neurosci Res 66:23–36CrossRefPubMed

Evans WH, Martin PE (2002) Gap junctions: structure and function. Mol Membr Biol 19:121–136CrossRefPubMed

Silander K, Meretoja P, Juvonen V, Ignatius J, Pihko H, Saarinen A, Wallden T, Herrgard E, Aula P, Savontaus ML (1998) Spectrum of mutations in Finnish patients with Charcot–Marie–Tooth disease and related neuropathies. Human Mutat 12:59–68CrossRef

Musso M, Balestra P, Bellone E, Cassandrini D, Di Maria E, Doria LL, Grandis M, Mancardi GL, Schenone A, Levi G, Ajmar F, Mandich P (2001) The D355V mutation decreases EGR2 binding to an element within the Cx32 promoter. Neurobiol Dis 8:700–706CrossRefPubMed

Warner LE, Svaren J, Milbrandt J, Lupski JR (1999) Functional consequences of mutations in the early growth response 2 gene (EGR2) correlate with severity of human myelinopathies. Hum Mol Genet 8:1245–1251CrossRefPubMed

Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P (1994) Krox-20 controls myelination in the peripheral nervous system. Nature 371:796–799CrossRefPubMed

10.

Mersiyanova IV, Ismailov SM, Polyakov AV, Dadali EL, Fedotov VP, Nelis E, Lofgren A, Timmerman V, van Broeckhoven C, Evgrafov OV (2000) Screening for mutations in the peripheral myelin genes PMP22, MPZ and GJB1 (GJB1) in Russian Charcot–Marie–Tooth neuropathy patients. Human Mutat 15:340–347CrossRef

11.

Choi BO, Lee MS, Shin SH, Hwang JH, Choi KG, Kim WK, Sunwoo IN, Kim NK, Chung KW (2004) Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot–Marie–Tooth neuropathy patients. Human Mutat 24:185–186CrossRef

12.

Bort S, Nelis E, Timmerman V, Sevilla T, Cruz-Martinez A, Martinez F, Millan JM, Arpa J, Vilchez JJ, Prieto F, Van Broeckhoven C, Palau F (1997) Mutational analysis of the MPZ, PMP22 and Cx32 genes in patients of Spanish ancestry with Charcot–Marie–Tooth disease and hereditary neuropathy with liability to pressure palsies. Hum Genet 99:746–754CrossRefPubMed

13.

Ikegami T, Lin C, Kato M, Itoh A, Nonaka I, Kurimura M, Hirayabashi H, Shinohara Y, Mochizuki A, Hayasaka K (1998) Four novel mutations of the connexin 32 gene in four Japanese families with Charcot–Marie–Tooth disease type 1. Am J Med Genet 80:352–355CrossRefPubMed

14.

Boerkoel CF, Takashima H, Bacino CA, Daentl D, Lupski JR (2001) EGR2 mutation R359W causes a spectrum of Dejerine–Sottas neuropathy. Neurogenetics 3:153–157CrossRefPubMed

15.

Taroni F, Pareyson D, Botti S, Sghirlanzoni A, Nemni R, Riva D (1999) Mutations in the Schwann cell transcription factor EGR2/Krox20 in patients with severe hereditary demyelinating neuropathies. Neurology 52 (Suppl 2):A258–A259CrossRef

16.

Timmerman V, De Jonghe P, Ceuterick C, De Vriendt E, Lofgren A, Nelis E, Warner LE, Lupski JR, Martin JJ, Van Broeckhoven C (1999) Novel missense mutation in the early growth response 2 gene associated with Dejerine–Sottas syndrome phenotype. Neurology 52:1827–1832PubMed

17.

Hattori N, Yamamoto M, Yoshihara T, Koike H, Nakagawa M, Yoshikawa H, Ohnishi A, Hayasaka K, Onodera O, Baba M, Yasuda H, Saito T, Nakashima K, Kira J, Kaji R, Oka N, Sobue G; Study Group for Hereditary Neuropathy in Japan (2003) Demyelinating and axonal features of Charcot–Marie–Tooth disease with mutations of myelin-related proteins (PMP22, MPZ and GJB1): a clinicopathological study of 205 Japanese patients. Brain 126:134–151CrossRefPubMed

Titel: Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot–Marie–Tooth disease family
verfasst von: K. W. Chung
I. N. Sunwoo
S. M. Kim
K. D. Park
W.-K. Kim
T. S. Kim
H. Koo
M. Cho
J. Lee
B. O. Choi
Publikationsdatum: 01.09.2005
Verlag: Springer-Verlag
Erschienen in: Neurogenetics / Ausgabe 3/2005
Print ISSN: 1364-6745
Elektronische ISSN: 1364-6753
DOI: https://doi.org/10.1007/s10048-005-0217-4

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

23.04.2024 | Demenz | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Two missense mutations of EGR2 R359W and GJB1 V136A in a Charcot–Marie–Tooth disease family

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2005

Identification of a VPS13A founder mutation in French Canadian families with chorea-acanthocytosis

Subcellular localization of spastin: implications for the pathogenesis of hereditary spastic paraplegia

The Gem interacting protein (GMIP) gene is associated with major depressive disorder

A G301R Na+/K+-ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs

Genetic heterogeneity for autosomal recessive pyridoxine-dependent seizures

Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Hustenstiller lindert Agitation bei Alzheimer

Update Neurologie